pubrio
Leucid Bio

Leucid Bio

United Kingdom · Research

Research

Leucid is progressing novel CAR T therapies that produce a better and more durable response than previous CAR T generations, improving treatment outcomes and saving the lives of patients with refractory cancers.

Company Insights
Company Overview

2014

Founded

Research

Industry

United Kingdom

Location

5,932,458

Ranking

24 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Leucid Bio

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​